Autoimmune pancreatitis in childhood

Česká verze

Authors: T. Sarnovská ¹; K. Jelínková ²; F. Neumann ³; D. Barnetová ¹; R. Hrdlička ¹
Authors place of work: Dětské oddělení, Oblastní nemocnice Kolín, a. s., nemocnice Středočeského kraje ¹; Radiodiagnostické oddělení, Oblastní nemocnice Kolín, a. s., nemocnice Středočeského kraje ²; Endoskopické centrum, Oblastní nemocnice Kolín, a. s., nemocnice Středočeského kraje ³
Published in the journal: Gastroent Hepatol 2023; 77(2): 136-139
Category: Dětská gastroenterologie a hepatologie: kazuistika
doi: https://doi.org/10.48095/ccgh2023136

Summary

Autoimmune pancreatitis is an idiopathic inflammatory disease of the pancreas that is rarely encountered even in paediatric patients. However, compared to adult patients, the clinical manifestation and course of the disease in children may differ. We present a case report of a 13-year-old boy admitted to our department with a history of abdominal pain, weight loss, vomiting, and sudden development of jaundice. Initial laboratory parameters showed signs of cholestasis, inflammatory parameters and pancreatic enzymes were in the normal range. ERCP examination demonstrated stenosis of the pancreatic part of ductus choledochus, sonography and MRCP examination showed lesion in the head of the pancreas and signs typical for autoimmune pancreatitis. Based on these findings, treatment with oral corticosteroids was started at an initial dose of 30 mg/day with a gradual reduction to the current maintenance dose, which is 5 mg of prednisone per day. The patient is currently in clinical remission; however, the exocrine dysfunction of the pancreas persists which we are solving by replacement of pancreatic enzymes. The aim of this paper is to present the basic features of the paediatric form of AIP and to point out the differences between AIP in children and adults.

Keywords:

immunoglobulin G4 – Steroids – autoimmune pancreatitis – paediatric autoimmune pancreatitis – MRCP

Zdroje

1. Dítě P, Ševčíková A, Novotný I et al. Autoimunitní pankreatitída v České republice – region jižní Morava. Čes Slov Gastroenter Hepatol 2007; 61 (2): 82–85.

2. Yoshida K, Toki F, Takeuchi T et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40 (7): 1561–1568. doi: 10.1007/BF02285209.

3. Scheers I, Palermo JJ, Freedman S et al. Autoimmune Pancreatitis in Children: Characteristic Features, Diagnosis, and Management. Am J Gastroenterol 2017; 112 (10): 1604–1611. doi: 10.1038/ajg.2017.85.

4. Shimosegawa T, Chari ST, Frulloni L et al. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas 2011; 40 (3): 352–358. doi: 10.1097/MPA. 0b013e3182142fd2.

5. Okazaki K, Chari ST, Frulloni L et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology 2017; 17 (1): 1–6. doi: 10.1016/j.pan.2016.12.003.

6. Scheers I, Palermo JJ, Freedman S et al. Recommendations for Diagnosis and Management of Autoimmune Pancreatitis in Childhood: Consensus from INSPPIRE. J Pediatr Gastroenterol Nutr 2018; 67 (2): 232–236. doi: 10.1097/ MPG.0000000000002028.

7. Morinville VD, Lowe ME, Ahuja M et al. Design and implementation of INSPPIRE. J Pediatr Gastroenterol Nutr 2014; 59 (3): 360–364. doi: 10.1097/MPG.0000000000000417.

8. Dítě Z, Novotný I, Kala Z et al. Pozitivita imunoglobulinu IgG4 v krevním séru u osob s karcinomem slinivky břišní. Gastroent Hepatol 2012; 66 (3): 187–190.

9. Dítě P, Novotný I, Kianička B et al. Autoimunitní pankreatitida – diagnostický konsenzus. Vnitř Lék 2015; 61 (2): 114–118.

10. Uvírová M, Bojková M, Novotný I et al. Problematika diferenciální diagnostiky autoimunitní formy pankreatitidy a pankreatického adenokarcinomu. Gastroent Hepatol 2014; 68 (6): 492–496. doi: 10.14735/amgh2014492.